In a study of more than 1,200 premenopausal women with HSDD, 25 percent of those who took bremelanotide saw some improvements in their reported sexual desire scores, compared with 17 percent who took a placebo. (iStock)
But how exactly does the drug work, and what makes it different from the other medication on the market?
The drug, called bremelanotide (brand name Vyleesi) has been approved to treat premenopausal women with ...
Read the full text foxnews